Blue Light Cystoscopy With Cysview® Registry
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
| Condition(s) | Bladder Cancer |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices. |
| Who can participate | Inclusion Criteria: * Adult \>18 years old * Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy Exclusion Criteria: * Porphyria * Gross hematuria * Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Photocure |
| Locations | Birmingham, Alabama, United States; Phoenix, Arizona, United States; Los Angeles, California, United States; Los Angeles, California, United States; Palo Alto, California, United States; San Francisco, California, United States (+17 more sites) |
| Start date | 2014-04 |
| NCT ID | NCT02660645 |
| Official listing | https://clinicaltrials.gov/study/NCT02660645 |